PULMONX CORP (LUNG) Stock Income Statement
NASDAQ:LUNG - Nasdaq - US7458481014 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 87.47M | 83.79M | 68.67M | 53.66M | 48.42M | |||
| Cost Of Goods | 23.21M | 21.79M | 17.92M | 13.80M | 12.79M | |||
| Gross Profit | 64.27M | 62.00M | 50.75M | 39.87M | 35.63M | |||
| Operating Expenses | 120.30M | 118.00M | 112.69M | 98.50M | 82.93M | |||
| Research and Development | 16.42M | 15.87M | 18.08M | 15.40M | 13.06M | |||
| Selling, General, and Administrative Expenses | 103.78M | 102.03M | 94.61M | 83.11M | 69.87M | |||
| Operating Income | -56.03M | -56.00M | -61.94M | -58.64M | -47.30M | |||
| Interest Income/Expense | 779.00K | 1.65M | 1.54M | 60.00K | -1.03M | |||
| Other Income/Expense | 308.00K | 156.00K | 127.00K | 0.00 | 20.00K | |||
| Non Recurring Items | N/A | -1.70M | N/A | N/A | N/A | |||
| Income Before Taxes | -56.64M | -55.89M | -60.27M | -58.57M | -48.32M | |||
| Income Tax | 449.00K | 500.00K | 571.00K | 350.00K | 340.00K | |||
| Net Income | -57.09M | -56.39M | -60.84M | -58.92M | -48.66M | |||
| EBITDA | -54.68M | -54.51M | -60.39M | -57.13M | -46.43M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.45 | -1.44 | -1.60 | -1.59 | -1.35 | |||
| Non GAAP EPS | -1.40 | -1.40 | -1.60 | -1.59 | -1.31 | |||
| Statistics | ||||||||
| Gross Profit Margin | 73.47% | 74.00% | 73.90% | 74.30% | 73.59% | |||
| Profit Margin | -65.27% | -67.30% | -88.60% | -109.80% | -100.50% | |||
| Operating Profit Margin | -64.06% | -66.84% | -90.19% | -109.28% | -97.69% | |||
All data in USD